32442084|t|Approaches to Optimizing Dantrolene Neuroprotection for the Treatment of Alzheimer's Disease.
32442084|a|Alzheimer's Disease (AD), a neurodegenerative disorder with high incidence and mortality, is leading its way to the top of the list of the deadliest diseases without an effective disease-modifying drug. Ca2+ dysregulation, specifically abnormal release of Ca2+ via over activated ryanodine receptor (RyR), has been increasingly considered as an alternative upstream mechanism in AD pathology. Consequently, dantrolene, a RyR antagonist and FDA approved drug to treat malignant hyperthermia and chronic muscle spasms, has been shown to ameliorate memory loss in AD transgenic mice. However, the inefficiency of dantrolene to pass the Blood Brain Barrier (BBB) and penetrate the Central Nervous System needs to be resolved, considering its dose-dependent neuroprotection in AD and other neurodegenerative diseases. In this mini-review, we will discuss the current status of dantrolene neuroprotection in AD treatment and a strategy to maximize its beneficial effects, such as intranasal administration of dantrolene.
32442084	25	35	Dantrolene	Chemical	MESH:D003620
32442084	73	92	Alzheimer's Disease	Disease	MESH:D000544
32442084	94	113	Alzheimer's Disease	Disease	MESH:D000544
32442084	115	117	AD	Disease	MESH:D000544
32442084	122	148	neurodegenerative disorder	Disease	MESH:D019636
32442084	297	301	Ca2+	Chemical	-
32442084	350	354	Ca2+	Chemical	-
32442084	374	392	ryanodine receptor	Gene	20190
32442084	394	397	RyR	Gene	20190
32442084	473	475	AD	Disease	MESH:D000544
32442084	501	511	dantrolene	Chemical	MESH:D003620
32442084	515	518	RyR	Gene	20190
32442084	561	583	malignant hyperthermia	Disease	MESH:D008305
32442084	596	609	muscle spasms	Disease	MESH:D013035
32442084	640	651	memory loss	Disease	MESH:D008569
32442084	655	657	AD	Disease	MESH:D000544
32442084	669	673	mice	Species	10090
32442084	704	714	dantrolene	Chemical	MESH:D003620
32442084	866	868	AD	Disease	MESH:D000544
32442084	879	905	neurodegenerative diseases	Disease	MESH:D019636
32442084	966	976	dantrolene	Chemical	MESH:D003620
32442084	996	998	AD	Disease	MESH:D000544
32442084	1097	1107	dantrolene	Chemical	MESH:D003620
32442084	Association	MESH:D013035	20190
32442084	Association	MESH:D008305	20190
32442084	Negative_Correlation	MESH:D003620	20190
32442084	Negative_Correlation	MESH:D003620	MESH:D008305
32442084	Negative_Correlation	MESH:D003620	MESH:D008569
32442084	Negative_Correlation	MESH:D003620	MESH:D013035
32442084	Negative_Correlation	MESH:D003620	MESH:D000544
32442084	Association	MESH:D000544	20190

